Fokkema, C., Bertamini, L., Jong, M. M. E. D., Tahri, S., Bruinink, D. H. O., Kellermayer, Z., Papazian, N., Hollander, C. D., Vermeulen, M. P. W., Stoetman, E. C. G., Beek, G. V., Hoogenboezem, R., Velden, V. H. J. V. D., Hulin, C., Perrot, A., Moreau, P., Rowe, M., Vieyra, D., Carson, R., Duin, M. V., Sanders, M. A., Broijl, A., Sonneveld, P., Cupedo, T. (2026). Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load. Blood. https://doi.org/10.1182/blood.2025030083